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Executive Summary 
A combination of policy and program efforts has contributed to the success of Massachusetts’s 
response to the HIV/AIDS epidemic. Advances in prevention, treatment, and diagnostic 
technologies coupled with the evolution of the public health and health care delivery system in 
the context of the federal Patient Protection and Affordable Care Act provide opportunities to 
further strengthen our response to the epidemic, and thereby build on successes to date.   
The Massachusetts State HIV/AIDS Plan (the Plan) articulates key recommendations which, 
when implemented, will enhance Massachusetts’s response to HIV/AIDS and will do so in a way 
which optimizes resources. The Plan emphasizes policy, structural, and operational adjustments. 
This reflects an acknowledgement of constrained funding and the evolving policy environment 
at the local, state, and national levels.  
While the Plan is specific to HIV/AIDS, it also articulates recommendations to strengthen 
Massachusetts’s response to hepatitis C virus (HCV) infection, including strategies to enhance 
programmatic efforts for the prevention, care, and treatment of HCV infection. 
The Plan is intended to inform and guide the HIV/AIDS prevention, care, and treatment activities 
of the Massachusetts Department of Public Health (MDPH).  These efforts are led by the Bureau 
of Infectious Disease (BID) Office of HIV/AIDS (OHA). The success of OHA’s efforts depends 
significantly upon the strength and effectiveness of a broad range of partnerships.  Therefore, 
the Plan should also serve as a guide for and inform the activities of providers, consumers, policy 
makers, researchers, community leaders, and other stakeholders.   
In implementing the Massachusetts State HIV/AIDS Plan, MDPH seeks to achieve three broad 
goals.   
Goal #1:  Reduce new HIV and HCV infections  
Goal #2:  Improve health outcomes (i.e. reduce disease-related morbidity and mortality) 
Goal #3:  Reduce disparities in HIV and HCV incidence and health outcomes 
Four objectives will advance achievement of these goals:   
1. Increase knowledge of HIV and HCV status 
2. Reduce risk for infection and/or transmission 
3. Increase sustained engagement in medical care and treatment 
4. Increase HIV viral suppression and sustained HCV virologic response 
Promotion and achievement of health equity in the prevention, care, and treatment of HIV/AIDS 
and HCV is an overarching objective.  Efforts and investments must be focused on and tailored 
to address the needs and priorities of individuals and communities disproportionately impacted 
by HIV/AIDS and HCV.  Most importantly, Massachusetts cannot anticipate ending the HIV 
epidemic without more effectively addressing prevention and care needs of gay and bisexual 
men and other men who have sex with men (MSM) of all races/ethnicities, and maintaining 
focus on the prevention and health protection needs of injection drug users (IDUs).  
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Implementation of five recommendations will strengthen Massachusetts’s response to HIV/AIDS 
and HCV by enhancing effectiveness, efficiency, and sustainability of programs and services.   
Recommendation #1: Strengthen Programmatic Response.  Given increasingly constrained 
resources, coupled with sustained or increasing need, Massachusetts will implement strategies 
to enhance targeting of services, focus its investments, and provide culturally relevant and 
responsive services. Massachusetts will also seek to enhance, at the state and local levels, 
capacity for evaluation and quality improvement essential to strengthening programmatic 
response.    
Recommendation #2: Strengthen the Evidence-Base for Decision Making. To enhance the 
effectiveness and efficiency of the response to HIV/AIDS and HCV, Massachusetts will expand 
the use of disease surveillance, service utilization, and other relevant sources of data in planning 
and evaluation of program and policy.  Massachusetts will also seek to address gaps in 
knowledge about the efficiency, effectiveness, and cost-effectiveness of services by enhancing 
evaluation of existing services, as well as of promising interventions and service models.  
Recommendation #3: Enhance Integration and Continuity of Services. Through refinement of 
policy and investment in capacity building, Massachusetts will facilitate and promote integration 
and continuity of communicable disease prevention, care, and treatment services. Through 
strategic partnerships, Massachusetts will also seek to promote integration and continuity of 
services in the context of primary care.   
Recommendation #4: Leverage Revenue from Third-Party Reimbursements. In order to 
facilitate a sustainable continuum of services, Massachusetts will implement strategies to 
increase capacity to, at the state and local levels, participate in third-party billing. Through 
strategic partnerships, Massachusetts will also seek to promote and facilitate the 
responsiveness of insurance products to the needs of individuals living with or at risk for 
HIV/AIDS, HCV, and other communicable diseases.  
Recommendation #5: Assure Sustainability of Services. In order to ensure that vital services 
continue to be available and accessible, Massachusetts will promote and facilitate enhanced 
collaboration between medical and non-medical providers who provide a range of clinical, 
social, and supportive services. Through strategic partnerships, Massachusetts will also 
articulate the public health impact of HIV/AIDS and HCV and the value of sustained investment 
in public health programming.   
The Massachusetts State HIV/AIDS Plan will inform the MDPH’s response to HIV/AIDS and HCV. 
Based on the recommendations and strategies articulated in this Plan, OHA will develop an 
implementation plan which describes concrete actions that will be taken to achieve the goals 
and objectives included in the Plan.  
OHA’s success in achieving the goals and objectives articulated in the Plan is predicated upon 
robust and successful partnerships with consumers, providers, and other stakeholders. Strategic 
partnerships are expected to play critical roles in advancing the strategies articulated in the 
Plan.  OHA is committed to transparency with and accountability to stakeholders as it advances 
the recommendations and strategies contained within the Plan and expects to regularly report 
on progress and challenges, and seek additional input from partners and advisory bodies in 
order to refine implementation strategies.   
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Introduction and Background 
Massachusetts’s response to the HIV/AIDS epidemic has 
been highly successful. Since 2000 there has been a 44 
percent decline in new HIV diagnoses and a 
corresponding 41 percent decline in deaths among state 
residents living with HIV/AIDS. This level of effectiveness 
is attributable to policy and program efforts designed to 
maximize access to prevention and care services, 
including Medicaid expansion and state health care 
reform. However, more remains to be done.  Advances in 
prevention, treatment, and diagnostic technologies along 
with changes in the policy and funding environment 
require Massachusetts to reexamine and refine its 
approach to the prevention, care, and treatment of HIV/AIDS.  Scientific advances coupled with 
the evolution of the public health and health care delivery system in response to 
implementation of the Patient Protection and Affordable Care Act (ACA), provide opportunities 
to strengthen our response to the epidemic, and thereby build on successes to date.   
The Massachusetts State HIV/AIDS Plan (the Plan) articulates key recommendations which, 
when implemented, will enhance Massachusetts’s response to HIV/AIDS and will do so in a way 
which can optimize resources.  The Plan emphasizes policy, structural, and operational 
adjustments. This reflects an acknowledgement of constrained funding and the evolving policy 
environment at the local, state, and national levels.  
The Massachusetts State HIV/AIDS Plan is intended to inform and guide the HIV/AIDS 
prevention, care, and treatment activities of the Massachusetts Department of Public Health 
(MDPH).  These efforts are led by the Bureau of Infectious Disease (BID) Office of HIV/AIDS 
(OHA). Because the success of OHA’s efforts depends significantly upon the strength and 
effectiveness of a broad range of partnerships, the Plan should also serve as a guide for and 
inform the activities of providers, consumers, policy makers, researchers, community leaders, 
and other stakeholders.   
While the Plan is specific to HIV/AIDS, it also articulates recommendations to strengthen the 
Commonwealth’s response to hepatitis C virus (HCV) infection, including strategies to enhance 
programmatic efforts for the prevention, care, and treatment of HCV infection. The reasons for 
addressing HCV in this Plan are multiple: both HIV and 
HCV are chronic infectious diseases of public health 
significance; the populations impacted by HIV and HCV 
significantly overlap; the transmission behaviors and 
contexts of risk overlap; and the care and treatment of 
HIV/AIDS and HCV are lengthy and often complex owing 
to co-morbid substance abuse and mental health issues 
implicated for both. The risks for HIV and HCV infection 
are grounded in psychosocial vulnerabilities and social 
determinants of health and require both individual-level 
and structural responses.  Over the more than 30 years of 
the HIV/AIDS epidemic, a well-developed infrastructure of 
HIV and HCV are both 
chronic diseases of public 
health significance with 
similarities in impacted 
populations, transmission 
behaviors, broader 
contexts of risk, and 
treatment complexities. 
The Plan is intended to 
inform and guide the 
HIV/AIDS prevention, 
care, and treatment 
activities of the MDPH as 
well as those of providers, 
consumers, policy makers, 
researchers, and others. 
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services for HIV prevention, care, and treatment has evolved which can and should be adapted 
to respond to the needs and priorities of individuals and populations affected by HCV.  Finally, 
responsibility for leading and coordinating the Commonwealth’s programmatic response to HCV 
resides with programmatic divisions of the Bureau of Infectious Disease (BID). 
Development of the Plan 
The Massachusetts State HIV/AIDS Plan was developed 
through a highly consultative process, led by OHA, with a 
broad array of stakeholders. The development process 
was initiated with a one-day meeting in which nearly 200 
individuals participated in facilitated discussion about the 
Plan, including development of specific recommendations 
to strengthen the Commonwealth’s response to 
HIV/AIDS.  Participants included medical providers, 
consumers, and representatives of organizations 
providing HIV/AIDS services (medical and non-medical), 
public health, behavioral health, and community mental 
health services.  
The discussion and recommendations that emerged from the one-day meeting were 
synthesized. The synthesis and recommendations were subsequently presented to and 
discussed with the State’s HIV planning group, the Massachusetts Integrated Prevention and 
Care Committee (MIPCC) and the Massachusetts Statewide Consumer Advisory Board (SWCAB).  
Both the MIPCC and the SWCAB function as advisory bodies, providing OHA with input and 
feedback regarding a range of policy and program issues. The MIPCC is comprised of 
representatives from agencies providing HIV/AIDS and HCV services and individuals representing 
communities impacted by HIV/AIDS and HCV.  The SWCAB is comprised of people living with 
HIV/AIDS (PLWHA).  Recommendations were further refined by OHA senior staff and 
incorporated into this Plan.  
The expertise of OHA and BID staff and leadership contributed to the development of this Plan.  
State and federal policy, including the White House’s National HIV/AIDS Strategy (NHAS), also 
shaped the development of this Plan.  
Status of the Epidemic in Massachusetts 
An estimated 26,000 to 28,000 people in Massachusetts are living with HIV, up to 18 percent of 
whom do not yet know they have HIV. There are currently 18,459 individuals living with 
HIV/AIDS in the Commonwealth, based upon case reports 
submitted to MDPH.  In 2011, the most recent year for 
which complete data are available, there were 657 new HIV 
diagnoses, compared with 1,175 in 2000.  This represents a 
44 percent decrease in annual diagnoses. The number of 
deaths among people reported with HIV/AIDS has 
decreased by 41 percent from 351 in 2000 to 208 in 2011. 
Success in achieving the 
goals and objectives 
articulated in the Plan is 
predicated upon robust 
and successful 
partnerships with 
consumers, providers, 
other stakeholders. 
 
Massachusetts has 
witnessed a 44% decrease 
in new HIV diagnoses and 
a 41% decrease in deaths. 
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Fifty-five percent of newly diagnosed men are members 
of racial/ethnic minorities, as are eighty percent of newly 
diagnosed women. To illustrate the health inequities, 
black (non-Hispanic) individuals make up six percent and 
Hispanic/Latino individuals make up eight percent of the 
total Massachusetts population. Forty-one percent of all 
new diagnoses occur among men who have sex with 
other men (MSM). Approximately one-third of all new 
diagnoses occur among individuals born outside of the 
United States, and 24 percent were reported with an 
exposure mode of No Identified Risk (NIR), the second 
largest exposure mode group among newly diagnosed 
individuals.   
Since 2002, 7,000 to 10,000 newly diagnosed cases of HCV infection have been reported 
annually to MDPH and it is estimated that there are 100,000 individuals in the Commonwealth 
that have been exposed to HCV.  Among those who died with a known HCV infection through 
2009, the median interval between diagnosis with HCV infection and death was three years, and 
the median age of death attributable to HCV infection was 53 years.  
While HIV infection among injection drug users (IDUs) in Massachusetts has declined 
significantly—92 percent in the past decade—there has not been a similar decrease in HCV 
infection in this population. In 2012, 70 percent of reported confirmed HCV infections that had 
risk factor information reported, had a history of injecting drugs. In the U.S., studies suggest that 
the prevalence of HCV among injecting drug users ranges from 40 to 90 percent. 
1, 2 
There has been a significant increase in HCV infection among young IDUs in Massachusetts that 
may signal the future direction of the HIV epidemic; annual reports of new HCV diagnosis in 
individuals between the ages of 15 and 24 years increased by 74 percent between 2001 and 
2009. Most of these individuals were likely exposed to HCV recently. Transmission in this age 
group is attributable primarily to injecting heroin and 
prescription opiates.  
Nearly one-third of people living with HIV/AIDS are co-
infected with HCV. Overall, HCV co-infected persons make 
up 15 percent of new HIV/AIDS diagnoses in 
Massachusetts. Among injecting drug users living with 
HIV, up to 59 percent are co-infected with HCV.  While 
antiretroviral therapy has extended the life expectancy of 
people living with HIV, liver disease primarily related to 
HCV infection is a leading cause of non-AIDS related 
deaths among PLWHA.  
                                                     
1
 Hagan, Pouget, Williams, et al. J Infect Dis. 2010; 201378-385. 
2
 Page, Hahn, Evans, et. Al. J Infect Dis. 2009; 200:1216-1226. 
Approximately 100,000 
Massachusetts residents 
have been exposed to HCV 
and there are up to 10,000 
new infections per year.  A 
significant portion of 
these new infections are 
among 15-24 year olds. 
In Massachusetts, 
populations 
disproportionately 
impacted by HIV/AIDS 
include: men who have 
sex with men, and 
racial/ethnic minorities, 
including those born 
outside of the United 
States. 
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In summary:  
• Mortality from HIV has decreased, and prevalence has increased.   
• The number of new HIV diagnoses has decreased, but nearly one in five individuals living 
with HIV may not be aware of their infection.   
• A significant proportion of individuals have concurrent HIV and AIDS diagnoses.   
• HIV/AIDS disproportionately impacts vulnerable populations, particularly: 
o Gay and bisexual men and other men who have sex with men (MSM) 
o Racial/ethnic minorities, notably non-Hispanic black and Hispanic/Latino individuals 
o Non-U.S. born state residents 
• HCV contributes significantly to morbidity and mortality among PLWHA. 
• HCV infection is increasing dramatically, related to injecting drug use particularly among 
adolescents and young adults, which has implications for the future direction of the HIV 
epidemic.  
A more detailed discussion of the impact of HIV/AIDS in Massachusetts is available on the OHA 
website at www.mass.gov/dph/aids  in the Massachusetts Epidemiologic Profiles section.  
Goals and Objectives 
In implementing the Massachusetts State HIV/AIDS Plan, MDPH seeks to achieve three broad 
goals.   
Goal #1:  Reduce new HIV and HCV infections  
Goal #2:  Improve health outcomes (i.e. reduce disease-related morbidity and mortality) 
Goal #3:  Reduce disparities in HIV and HCV incidence and health outcomes 
Four objectives will advance achievement of these goals:   
1. Increase knowledge of HIV and HCV status 
2. Reduce risk for infection and/or transmission 
3. Increase sustained engagement in medical care and 
treatment 
4. Increase HIV viral suppression and sustained HCV 
virologic response 
Promotion and achievement of health equity in the 
prevention, care, and treatment of HIV/AIDS and HCV infection is an overarching objective.  
Efforts and investments must be focused on and tailored to address the needs and priorities of 
individuals and communities disproportionately impacted by HIV/AIDS and HCV.  Most 
importantly, Massachusetts cannot anticipate ending the HIV epidemic without more effectively 
addressing prevention and care needs of gay and bisexual men, and other men who have sex 
Health equity for MSM , 
IDU, and racial/ethnic 
minority populations 
related to the prevention, 
care, and treatment of 
HIV/AIDS is an 
overarching objective. 
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with men (MSM) of all races/ethnicities, and maintaining focus on the prevention and health 
protection needs of injection drug users (IDUs).  
Expected Impact 
Progress toward achievement of the goals articulated in 
this Plan will be assessed through monitoring of selected 
impact measures, presented below.  By 2016 the 
Commonwealth will:  
1. Reduce newly diagnosed HIV infections by 5%, from 
660 to 627. 
a. Reduce new HIV infections among MSM by 2%, 
from 271 to 266. 
b. Reduce new HIV infections among black residents 
by 5%, from 208 to 198. 
c. Reduce new HIV infections among Hispanic/ 
Latino residents by 3%, from 188 to 182. 
2. Reduce the disparity in relative rates of new infections between: 
a. Black and white residents by 20%, from 10 to 8 times. 
b. Hispanic/Latino and white residents by 25%, from 8 to 5.25 times. 
3. Reduce mortality in PLWHA by 12%, from 257 to 226. 
a. Reduce mortality among IDU with HIV infection by 25%, from 89 to 69. 
4. Decrease incidence of opportunistic infections among PLWHA by 25%, from 104 to 78. 
5. Increase by 10% the proportion of HCV antibody positive 
cases that receive a nucleic acid amplification test (NAAT) or 
other test to confirm active infection, from 55 % to 65%. 
6. Increase by one year the median survival time from diagnosis 
of individuals with HCV infection from 53 to 54 years.  
Impact measures are based on currently available data and reflect 
cases reported through June 1, 2013. As data systems mature and 
data sets become more robust, these measures will be refined 
and/or replaced. Baseline and targets will be updated as 
necessary.   
 
Massachusetts expects 
reductions in the number 
of new HIV infections, in 
health disparities related 
to HIV diagnosis, in HIV 
mortality, and in the 
number of opportunistic 
infections. 
 
Massachusetts also 
expects an increase in the 
number of people who 
receive follow-up HCV 
testing and an increase of 
survival for people living 
with HCV. 
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Recommendations and Strategies 
The recommendations and strategies presented below are intended to strengthen 
Massachusetts’s response to HIV/AIDS and HCV by enhancing effectiveness, efficiency, and 
sustainability of programs and services.   
Recommendation #1: Strengthen Programmatic 
Response.  
Given increasingly constrained resources, coupled with 
sustained or increasing need, it is critical to direct efforts 
in a way which will optimize resources and have the 
greatest impact.   
 
Strategies to achieve a strengthened response include: 
• Refine and strengthen targeting of services.  Decisions regarding targeting should be data-
driven and services should be targeted according to:  
o Population:  Priority should be placed on serving populations disproportionately or 
increasingly impacted by HIV/AIDS and/or HCV. 
o Geography: Proportionally prioritize geographic areas of the Commonwealth which have 
the greatest disease burden or increasing incidence. 
o Venue: Prioritize venues which serve and/or can provide access to populations at 
highest risk and/or hard-to-reach (e.g. correctional facilities or public sex environments).  
o Acuity: Implement strategies (e.g. risk screening or acuity assessments) to identify 
individuals at highest risk, in greatest need, and/or who could most benefit from 
services.  
• Focus program efforts and investments. Interventions and services should be evidence-
based and aligned with achievement of the overarching goals articulated in this Plan.  
Priority should be placed on strengthening interventions and services that align with 
achieving programmatic objectives.  
• Construct a service portfolio responsive to community needs and provider capacities. In 
constructing a service portfolio: 
o Employ a mixture of strategies, technologies, and models.  Implementation of a range of 
interventions and services facilitates responsiveness to the unique needs of clients and 
communities, and enables delivery of interventions and services within the resources 
and capacities of a range of service providers.  A particular emphasis should be placed 
on reducing service gaps and increasing alignment and collaboration within regional 
networks of providers with complementary capacities, notably medical and non-medical 
providers.  
 Massachusetts will 
enhance targeting of 
services, focus 
investments, and provide 
culturally relevant and 
responsive services. 
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o Adopt new and emerging tools and technologies to facilitate responsiveness to the 
evolving needs of clients, populations, and communities, as well as capacities and 
resources of service providers.   
o Collaborate with health economists to identify the mix of strategies that will result in 
the greatest impact with regard to reducing incidence and promoting positive health 
outcomes.   
o Pilot promising interventions and service models (e.g. brief strengths-based case 
management, novel testing technologies).  Pilots should be accompanied by robust 
evaluation to identify what works and where in order to inform replication.  
o Implement health communications/social marketing campaigns designed to increase 
awareness of disease impact, drive service access and utilization. Address stigma and 
norms implicated in risk, and that create barriers to prevention, care, and treatment.  
• Strengthen capacity for programmatic monitoring, evaluation, and quality improvement.  It 
is critical to ensure that program efforts are targeted, tailored, effective, and efficient, and 
accomplish the intended health outcomes.  Monitoring and evaluation (M&E) and quality 
improvement (QI) facilitate identification and leverage of programmatic strengths and/or 
focus in on areas where opportunities for improvement exist.  They also enhance 
accountability. Strategies for strengthening M&E and QI include: 
o Address M&E and QI in program standards for HIV and HCV prevention, care, and 
treatment services. 
o Strengthen contract management protocols and procedures with regard to assessing 
the implementation of M&E and QI activities by providers of HIV and HCV prevention, 
care, and treatment services. 
o In collaboration with academia or other sources 
of relevant expertise, enhance the capacity of 
service providers to perform M&E and QI of HIV 
and HCV prevention, care, and treatment 
services.  Capacity building strategies may include 
development and dissemination of guidelines and 
sample tools and protocols, education and 
training, and individualized technical assistance.    
• Strengthen capacity to provide culturally relevant and appropriate services with regard to 
race/ethnicity, sexual orientation, gender identity, country of origin, age, HIV and HCV 
infection status.  HIV and HCV prevention, care, and treatment services must be culturally 
relevant and appropriate in order to be effective.  Providers of such services must have the 
knowledge, skills, and competencies to provide such services.  Strategies to strengthen 
capacity to provide culturally competent services may include:  
o Address cultural competence in program standards for HIV and HCV prevention, care, 
and treatment services. 
o Strengthen contract management protocols and procedures with regard to assessing 
the cultural competence of HIV and HCV prevention, care, and treatment services. 
o Enhance the capacity of service providers to provide culturally, linguistically, and 
developmentally competent services.  Capacity building strategies may include 
 Massachusetts seeks to 
enhance capacity for 
evaluation and quality 
improvement at state and 
local levels. 
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development and dissemination of guidelines, education, training, and individualized 
technical assistance.  Collaborate with state, regional, and national partners in provision 
of capacity building assistance (e.g. National LGBT Health Education Center). 
o Partner with other MDPH programs (e.g. Bureau of Substance Abuse Services) to 
strengthen the cultural competence of substance abuse, mental health, and correctional 
health providers with regard to sexual minorities and drug users.   
Recommendation #2: Strengthen the Evidence-
Base for Decision Making.   
The effectiveness and efficiency of Massachusetts’s 
response to HIV/AIDS and HCV is predicated upon well-
informed decision-making.   
Strategies to strengthen the evidence-base for decision making include:  
• Expand and enhance use of disease surveillance data including electronic laboratory 
reporting (ELR) and provide timely and relevant analysis to providers and other stakeholders.  
These data can inform program planning, evaluation, and quality management as well as 
stimulate practice improvement at state, regional, and provider levels.   Novel uses could 
include:   
o Generate state, regional, and facility-specific care cascades.  Provision of support to 
providers will be needed to assure timely application of these data to program planning, 
evaluation, and practice improvement efforts.  
o Use surveillance data to identify out-of-care clients or clients who may be receiving sub-
optimal care.  Strengthening the relationship between providers and disease 
surveillance and disease intervention programs will be essential to support this novel 
use of data.   
o Calculate HIV community viral load estimates and assess their usefulness to focusing 
program response and investments.   
o Perform combined analysis of disease surveillance data from related health areas (e.g. 
HIV, sexually transmitted infections, HCV, tuberculosis) to gain a better understanding 
of co-occurring morbidity and to identify emerging trends. Provision of support to 
providers will be needed to assure timely application of these data to program planning, 
evaluation, and practice improvement efforts.  
• Strengthen and expand application of service utilization data to program planning, 
evaluation, and quality improvement efforts.  Service utilization data are essential to 
describe program investments, monitor progress toward achieving goals and objectives, 
evaluate the effectiveness and efficiency of services, and inform quality management.  Data 
systems, including analytic and dissemination strategies, must enable and optimally 
facilitate these functions across a continuum of prevention and care services.  Actions 
needed to strengthen and expand application of service utilization data include: 
o Develop a comprehensive monitoring and evaluation (M&E) plan to articulate goals, 
objectives and expected outcomes, and to inform data collection, management and 
application plans and priorities. The M&E plan should be responsive to national 
Massachusetts will use 
disease surveillance and 
service utilization data for 
planning and evaluation. 
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performance standards and articulate benchmarks against which progress can be 
monitored.  
o Refine and streamline existing data collection requirements and data management 
strategies to ensure essential data elements are collected, while simultaneously 
reducing reporting burden. 
o Develop data management systems and processes which assure integration of service 
utilization data across the continuum of prevention and care services, which reflects 
communicable disease service integration; which enables use of service utilization data 
in conjunction with disease surveillance, and other sources of client-level data; and 
which assures providers real-time access to service data needed for program monitoring 
and quality management.    
o Implement mechanisms to assure that service utilization data for related programs 
supported by MDPH (such as refugee and immigrant health programs, substance abuse 
services, tuberculosis, and correctional health) are routinely analyzed to monitor 
responsiveness to standards of care, health outcomes, and fidelity to intervention and 
service guidelines; and to identify gaps in services and opportunities for enhanced 
collaboration and service integration.  
• Address critical gaps in knowledge about the 
efficiency, effectiveness, and cost of services through 
evaluation of existing services, as well as of promising 
interventions and service models.  This knowledge is 
essential to ensure resources are invested in services 
and activities that will result in improved outcomes 
and which optimize resources and achieve cost-
efficiencies.  Strategies to address knowledge gaps 
include:  
o Implement outcome-based monitoring of prevention and care services and assure that 
outcome standards are clearly articulated and are consistent across related programs 
supported by MDPH (e.g. refugee and immigrant health programs, substance abuse 
services, correctional health).   
o In collaboration with academic, community, and other partners implement, via pilot or 
demonstration projects, evaluation of essential prevention and care services (e.g. 
population-based screening, patient navigation, HIV/HCV prevention strategies for 
young IDUs, and medical case management) to provide evidence of the effectiveness of 
achieving health outcomes, as well as cost-effectiveness of these services.   
o In collaboration with academic, community and other partners implement, via pilot or 
demonstration projects, evaluation of new and promising interventions and service 
models (e.g. case management for high-risk negatives or HCV mono-infected individuals, 
pre-exposure prophylaxis for HIV).  Evaluation activities should support and guide 
replication of demonstrably effective interventions and service models.  
• Explore novel uses for existing data sets to focus and evaluate program efforts and the 
impact of policy decisions.  Data gathered by other programs and for other purposes can be 
useful for program planning and evaluation and should be used to ensure a more robust 
base of knowledge from which to make decisions.  For example, research demonstrates an 
 Massachusetts will work 
to increase knowledge 
about the efficiency, 
efficacy, and cost-
effectiveness of various 
HIV-related services. 
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association between HIV seroprevalence and low socioeconomic status.  Use of census tract 
data may be useful in focusing prevention efforts.     
Recommendation #3: Enhance Integration and 
Continuity of Services.  
Integrating prevention, care, and treatment services for 
HIV, HCV, STIs, and other communicable diseases can 
improve the quality and continuity of client care as well as 
the efficiency of service provision. 
 
Strategies to enhance integration and continuity of services include:  
• Promote and facilitate integration and continuity of communicable disease prevention, care, 
and treatment services supported by MDPH through implementation of enabling policy.  
Policy adjustments that can promote and facilitate integration and continuity include: 
o Promote and facilitate across MDPH program areas (e.g. infectious disease, substance 
abuse services, and family planning), unified program standards for HIV, STI, HCV, and 
other communicable disease prevention, care, and treatment services.   
o Promote and facilitate across MDPH program areas (e.g. infectious disease, substance 
abuse services, and family planning), health outcome indicators that reflect 
accountability for achieving continuity in HIV and HCV prevention and care services. 
o Integrate procurements, if feasible, for HIV and HCV prevention, care, and treatment 
services and/or adopt consistent contractual requirements, program standards, and 
accountability measures across procurements supporting such services. 
o Leverage state, federal, and other resources (e.g. private or foundation resources) to 
afford maximum flexibility to local providers in offering a full range of HIV and HCV 
prevention, care, and treatment services, to eligible clients regardless of HIV status.   
o Expand advisory body membership to ensure representation of consumer perspectives 
and provider expertise across HIV, HCV, STIs, and other communicable diseases.  
o Promote a coordinated state response to HIV and HCV prevention and care across state 
agencies (e.g. Department of Elementary and Secondary Education, Department of 
Corrections) and with local boards of health. Achievement of the goals and objectives 
articulated in this Plan are predicated upon coordination of activities and resources 
among agencies and across levels of government. 
• Strengthen the capacity of local service providers to integrate and provide continuity in 
communicable disease prevention, care, and treatment services. A variety of capacity 
building strategies, modalities, and partners can be considered including: 
o Facilitate and support cross-training of prevention, care, and treatment providers, in a 
range of settings and venues (e.g. community health centers, substance abuse 
treatment, corrections, community-based organizations), regarding the importance of 
and strategies to integrate HIV, HCV, and STI prevention, care and treatment services. 
Strategic partnerships will 
promote integration and 
continuity of services for 
the prevention, care, and 
treatment of HIV, HCV, 
and STIs. 
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o In collaboration with the Ratelle HIV/STD Prevention Training Center (PTC), the New 
England AIDS Education and Training Center (NEAETC), and others (e.g. medical, dental, 
and nursing associations) advance integration of public health and prevention strategies 
including pre-exposure prophylaxis for HIV (PrEP), partner services, and prevention 
counseling into medical care, including medical care for HIV and HCV infection. 
• Promote and facilitate integration of HIV and HCV prevention, care, and treatment services 
into primary care. Strategies may include:  
o Collaborate with the Massachusetts League of Community Health Centers to implement 
a campaign and associated capacity building activities designed to advance 
implementation of routine screening for HIV and HCV, pursuant to state and federal 
recommendations, as a component of primary care.  
o Partner with the New England AIDS Education and Training Center (NEAETC) and others 
(e.g. medical, dental, and nursing associations) to promote and build capacity for the 
medical management of HIV and HCV (including HIV/HCV co-infection) in the context of 
primary care, including support for adoption of strategies such as expert clinical 
consultation and telemedicine.   
Recommendation #4: Leverage Revenue from 
Third-Party Reimbursements.   
With increasingly constrained resources, revenue 
generated by participation in third-party billing will allow 
other funds, including those made available through 
federal grant opportunities, to be directed to other critical 
program areas and activities.    
Recommendations to leverage revenue generated from third-party reimbursement include:  
• Address gaps in knowledge with regard to billing opportunities for prevention and care 
services, and the resulting impact on access to and utilization of these services. In 
collaboration with providers, consumers, and other stakeholders, conduct formative 
research to describe and quantify the potential impacts that mandated billing of third-party 
payers has for access to and utilization of a range of HIV/AIDS, HCV, and other 
communicable disease services.  Findings from research should inform MDPH policy changes 
regarding third-party billing for such services.  
• Increase revenue for prevention and care services through reimbursement from third-party 
payers.  Leveraging resources available through third-party reimbursement enables 
redirection of grant and categorical funds to other priority services and activities which are 
not reimbursable. Actions to support building capacity for and implementation of third-
party billing and reimbursement include: 
o Identify and describe essential prevention and care services and assess which are and 
are not reimbursable by third-party payers.  Assess which services are reimbursable and 
in which contexts (e.g. by venue or credentialing of service provider), as well as the 
amount of reimbursement provided.   
 Leveraging third-party 
reimbursement enables 
redirection of grant and 
categorical funds to other 
priority services. 
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o Assess MDPH and local provider capacity for and current practices with regard to 
participation in third-party billing and reimbursement.  Use findings from assessment 
activities to inform capacity building activities.   
o Assess billing requirements across provider and venue types, including medical and non-
medical agencies, and identify requirements to function as an authorized biller by 
provider license or certification; and/or strategies to enable reimbursement of services 
delivered by agencies that may lack the capacity to directly participate in third-party 
billing and reimbursement. 
o In partnership with related programs (e.g. refugee and immigrant health, substance 
abuse services), identify and adopt strategies (e.g. certification programs) that, where 
feasible, facilitate third-party reimbursement of services provided by peers, community 
health workers, and others.   
o Assess the extent to which prevention and care (e.g. HIV, HCV, and STI screening, 
prevention services, patient navigation, and medical case management) services are 
successfully reimbursed by MassHealth. 
o In partnership with the state Office of Medicaid explore opportunities to establish HIV 
Health Homes, established by section 2703 of the Affordable Care Act, entitled “State 
Option to Provide Health Homes for Enrollees with Chronic Conditions” as a mechanism 
to enhance care coordination and health outcomes for PLWHA who are Medicaid 
beneficiaries.   
o Ascertain costs associated with provision of essential prevention and care services.  
Understanding the cost of specific services can inform setting payment rates to 
adequately reimburse for services provided.  Cost calculations should reflect complexity 
of needs and services.  
o In collaboration with the Center for Health Information and Analysis (CHIA) investigate 
potential rate structures for HIV and HCV prevention and care services that would be in 
compliance with chapter 257 of the Acts of 2008.  Providers will require technical 
assistance to implement billing in compliance with c. 257.    
o Facilitate provision of capacity development and 
technical assistance to support and enhance the 
successful participation of providers in third-party 
billing and reimbursement.  
o Expand provider participation in third-party billing 
and reimbursement through policy interventions 
such as mandating that MDPH-funded providers 
obtain insurance information at intake and that 
those providers with the capacity to do so, seek 
reimbursement for billable services (e.g. HIV 
screening).   
• Facilitate responsiveness of insurance products to the needs of individuals living with or at 
risk for HIV/AIDS, HCV, and other communicable diseases. In order to obtain maximum 
benefit of health care reform, the needs of individuals living with and at risk for HIV/AIDS, 
HCV and other communicable diseases must be adequately addressed by insurance 
Capacity building, 
technical assistance, and 
policy development 
activities will support 
providers as they explore 
and take advantage of 
third-party billing 
opportunities. 
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products such as essential health benefits, drug formularies, and prescription coverage.  
Actions to facilitate responsiveness may include:  
o Advocate with the state Office of Medicaid and other third-party payers as well as the 
Commonwealth Connector Board to ensure that insurance products are responsive to 
the needs of individuals living with and at risk for HIV/AIDS, HCV, and other 
communicable diseases and are adequately addressed in formularies, essential health 
benefits, and prescription coverage.   
o In collaboration with academic, community, and other partners, implement a 
demonstration project that makes a business case for the cost-effectiveness of 
prevention and care services including population-based screening for HIV and HCV; 
medical case management services (for individuals living with HIV/AIDS, mono-infected 
with HCV, and co-infected with HIV and HCV); peer support, and patient navigation 
services.    
Recommendation #5: Assure Sustainability of 
Services.  
Changes to the health care system stimulated by 
implementation of ACA, combined with uncertain funding 
for HIV/AIDS and HCV services, and other factors (e.g. 
advances in treatment) require adjustments in the service 
delivery system and approach in order to ensure that vital 
services are available and accessible to the individuals and 
communities which need them. 
Strategies to ensure sustainability of services include: 
• In collaboration with community leaders, consumers, and other stakeholders articulate the 
public health impact of HIV/AIDS and HCV and the importance of making a sustained 
investment in prevention, care, and treatment services.  Highlight the continued need for 
and role of public health and community partners in a post-health care reform environment.  
• Promote and facilitate enhanced coordination and collaboration between medical and non-
medical providers to assure access to a range of services responsive to client needs and 
priorities. Strategies may include: 
o Implementing various models of inter-agency collaboration including staff “out-
posting,” co-location of services, and regional service networks.  Operational models 
should be evaluated to assess effectiveness in facilitating access to and continuity of 
services.  
o Promote and facilitate collaborations between community health centers and non-
medical community-based service providers to implement health home models for the 
care and treatment of HIV and HCV, including HIV/HCV co-infection.    
o Translate lessons learned from the Massachusetts demonstration project of dually-
eligible Medicaid/Medicare beneficiaries to transforming the HIV/AIDS services system 
into an Integrated Care Organization (ICO) model.   
Massachusetts will 
promote and facilitate 
enhanced collaboration 
between medical and non-
medical providers to 
support provision of a 
continuum of prevention 
and care services. 
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• Identify and implement strategies to consolidate prevention, care, and treatment services.  
Consolidation of services through organizational merger, joint operating agreements, sub-
contracts, and/or memoranda of agreement can help to achieve efficiencies (e.g. reducing 
administrative costs), ensure continued access to services, and enhance integration and 
continuity of services.  
Discussion and Next Steps 
The Massachusetts State HIV/AIDS Plan will inform the MDPH’s response to HIV/AIDS and HCV. 
Based on the recommendations and strategies articulated in this Plan the OHA will develop an 
implementation plan to describe concrete actions that will be taken by OHA, and associated 
timelines to achieve the goals and objectives presented in the Plan.  
The extent to which OHA can be successful in achieving the goals and objectives articulated in 
the Plan will be predicated upon robust and successful partnerships with consumers, providers 
other stakeholders. Partners play critical roles in enacting the recommendations and strategies 
articulated in the plan.  For this reason, OHA will disseminate the Massachusetts State HIV/AIDS 
Plan widely and will encourage stakeholders to align activities with the Plan.  OHA will also use 
dissemination of the Plan as an opportunity to promote collaboration and partnership.   
The Office of HIV/AIDS is committed to transparency with, 
and accountability to, stakeholders as it advances the 
recommendations and strategies contained within the 
Plan and expects to regularly report on progress and 
challenges, and seek additional input from partners and 
advisory bodies in order to refine its approach and 
strategies.  Mechanisms through which OHA will 
demonstrate accountability to stakeholders will be 
addressed in a forthcoming Implementation Plan.   
 
 
 
 
Massachusetts will be 
transparent with, and 
accountable to, all 
stakeholders as the Plan is 
implemented. 
